Why Is Indian Stock Market Rising? Sensex Surges Over 800 Points, Nifty Reclaims 25,000

Last Updated:
Sensex and Nifty 50 posted strong intraday gains on Friday, June 20, defying escalating tensions between Israel and Iran
Why Is Market Rising Today? Indian stock market benchmarks Sensex and Nifty 50 posted strong intraday gains on Friday, June 20, defying escalating tensions between Israel and Iran.
The Sensex opened slightly lower at 81,354.85 compared to its previous close of 81,361.87 but surged over 800 points, or 1%, to touch an intraday high of 82,186.37. Similarly, the Nifty 50 began at 24,787.65 and climbed 1% to hit an intraday peak of 25,040.45 from its previous close of 24,793.25.
Among the top gainers on the Sensex were Bajaj Finserv, Mahindra & Mahindra, UltraTech Cement, SBI, Eternal, Maruti Suzuki, and Axis Bank, all rising up to 1.5%. However, IndusInd Bank, Bajaj Finance, Tech Mahindra, and Titan opened in negative territory.
In contrast, Asian markets opened on a subdued note following reports of Israel bombing Iranian nuclear facilities, which prompted retaliatory missile and drone attacks from Iran.
Meanwhile, the White House stated that President Donald Trump would decide within two weeks whether the US would provide military support to Israel.
Investor sentiment remained upbeat in Indian markets, reflected in the rise in overall market capitalisation of BSE-listed companies, which grew by nearly Rs 3 lakh crore to reach Rs 446 lakh crore, up from Rs 443 lakh crore in the previous session.
Following three sessions of subdued trade, Indian equities are bouncing back as investors take advantage of attractive stock valuations. Experts believe the underlying economic fundamentals remain strong, prompting renewed buying interest and short covering in key sectors.
A sharp decline in crude oil prices has provided a tailwind to the market. Brent crude slipped over 2% to near $77 per barrel, easing inflationary and fiscal concerns. Despite escalating Middle East tensions, the fall is attributed to profit booking and uncertainty surrounding potential US intervention in the Israel-Iran conflict.
White House Press Secretary Karoline Leavitt confirmed that President Donald Trump is expected to make a decision on US involvement within two weeks, keeping geopolitical anxiety high but market reaction measured for now. Analysts say oil remaining below $80 per barrel is a positive sign for Indian equities.
FPIs Resume Buying
Foreign portfolio investors (FPIs) have been buying Indian equities for the last three consecutive sessions amid a decline in the dollar index. On June 19, FPIs bought Indian equities worth ₹934.62 crore in the cash segment. As the Indian economy's macro outlook remains strong, experts believe foreign investors could be eying fairly valued segments of the stock market after the recent fall.
What Should Investors Do?
'Nifty, which has been trading within the 24500-25000 range for about a month now, is likely to remain within this range in the near term. The upper side of the range will be broken only on news of de-escalation of the Israel-Iran conflict or an abrupt end to the war. The lower side of the range is unlikely to break since big buying, particularly by domestic institutions, will emerge on dips. If the war lingers and crude rises beyond $85, the lower band of the range will be broken," said Dr. VK Vijayakumar, Chief Investment Strategist, Geojit Investments.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Standard

27 minutes ago

• Business Standard

DHFL case: Expeditiously decide Kapil Wadhawan bail plea, SC tells Delhi HC

The Supreme Court on Friday asked the Delhi High Court to decide within two weeks the bail plea of Dewan Housing Finance Ltd's former promoter Kapil Wadhawan in the multi-crore bank fraud case investigated by the CBI. A bench of Justices Ujjal Bhuyan and Manmohan said Wadhawan was in custody since July, 2022 and his bail plea was coming up for hearing on July 18 in the high court. The bench asked the high court to decide the bail plea within two weeks from the date of hearing. Wadhawan moved the top court aggrieved by the orders of adjournment in his bail plea by the high court and sought an expeditious disposal of his petition. Senior advocate Siddharth Luthra, appearing for Kapil Wadhawan, referred to his client's long custody period aside from the non-adjudication on his bail plea on multiple occasions. The Wadhawan brothers -- Kapil and Dheeraj -- were arrested in this case on July 19, 2022. Dheeraj was granted interim bail by the high court on September 9, last year on medical grounds. The chargesheet was filed by the CBI on October 15, 2022 and cognisance was taken by the trial court. The FIR in the case was based on a complaint made by the Union Bank of India. The CBI alleged that Dewan Housing Finance Ltd (DHFL), its then CMD Kapil, then director Dheeraj and other accused persons conspired to cheat the consortium of 17 banks led by the Union Bank of India. The accused and others induced the consortium to sanction huge loans aggregating Rs 42,871.42 crore. Much of the amount was allegedly siphoned off and misappropriated by alleged falsification of the books of the DHFL and dishonest default in repayment of the legitimate dues of the consortium banks, the CBI claimed. The complainant alleged that a wrongful loss of Rs 34,615 crore was caused to the consortium banks in as much as such was the quantification of the outstanding dues as on July 31, 2020.

Business Standard

28 minutes ago

• Business Standard

Tata AIA launches 2 new funds for wealth creation, insurance cover

Tata AIA Life Insurance has launched two new equity-linked funds (ULIP) under its unit-linked insurance plans (ULIPs). Top 200 Alpha 30 Index Fund and Top 200 Alpha 30 Index Pension Fund will be available from June 23 to June 30, 2025, at an issue price of Rs 10 per unit. Both funds are meant for wealth creation and retirement planning while offering life insurance protection under various Tata AIA insurance products, said the company. 1. Top 200 Alpha 30 Index Fund It is meant for individuals looking to create wealth while providing insurance cover to their families. The fund is benchmarked to the Nifty 200 Alpha 30 Index, which includes 30 high-performing stocks known to generate excess returns (alpha) over the market. 2. Top 200 Alpha 30 Index Pension Fund It will build a robust retirement corpus and is available through Tata AIA's Smart Pension Secure Plan. Both funds have the following asset allocation: 80 per cent to 100 per cent in equity and equity-related instruments Zero per cent to 20 per cent in cash and money market securities Features for investors Access to Alpha Stocks: Focus on companies with a strong track record of outperforming the market. Life insurance: Investors get insurance cover along with market-linked returns. Long-term wealth Focus: Ideal for financial goals that span several years, like retirement. Strategic diversification: Exposure to multiple sectors with a data-driven stock selection process. 'The new funds are positioned to capitalise on India's strong economic fundamentals and rising consumption,' said Harshad Patil, Chief Investment Officer, Tata AIA Life Insurance. 'We are combining life cover with high-growth equity exposure, giving customers both financial protection and investment growth.' Tata AIA funds' performance Top 200 Fund: 32.3 per cent CAGR in five years Multi-Cap Fund: 31.4 per cent India Consumption Fund: 30.4 per cent Notably, 99.93 per cent of Tata AIA's fund assets under management are rated 4 or 5 stars by Morningstar, much higher than the industry average of less than 30 per cent. How to invest? Investors can access these funds through select Tata AIA life insurance products such as: Param Raksha Life Growth+ / Pro / Maxima+ Pro Fit Shubh Muhurat Shubh Fortune

News18

36 minutes ago

• News18

Lilavati Trust Slaps Rs 1,000-Crore Defamation Suit On HDFC Bank CEO Sashidhar Jagdishan; Details Here

The Lilavati Kirtilal Mehta Medical Trust filed a Rs 1,000 crore defamation lawsuit and a criminal complaint against HDFC Bank CEO Sashidhar Jagdishan for alleged false statements. In an escalation of the ongoing dispute, the Lilavati Kirtilal Mehta Medical Trust (LKMM Trust) has filed a Rs 1,000 crore civil defamation lawsuit against HDFC Bank Managing Director & CEO Sashidhar Jagdishan, accusing him of making 'malicious, false and defamatory" statements against the Trust and its permanent trustee Prashant Mehta. In an official statement, the Trust said, 'The Lilavati Kirtilal Mehta Medical Trust (LKMM Trust) has filed a Rs 1,000 crore civil defamation lawsuit against Mr. Sashidhar Jagdishan, Managing Director & CEO of HDFC Bank, over a series of malicious, false, and defamatory statements made against the Trust and its Permanent Trustee, Mr. Prashant Mehta." The Lilavati Hospital, one of Mumbai's best-known healthcare institutions, operates under the aegis of the LKMM Trust. 'Coordinated Smear Campaign' The Trust alleged that Jagdishan launched a 'coordinated campaign to malign its reputation and obstruct its operations as a public charitable institution." In a parallel move, the Trust has also filed a criminal complaint before the Metropolitan Magistrate of Girgaon, Maharashtra. The court has issued notices to Sashidhar Jagdishan, HDFC Bank's spokesperson, and its corporate communication head. The Trust described the legal action as a vital step forward. 'The criminal complaint and subsequent notice mark a significant step in holding the HDFC CEO accountable for what the Trust alleges is a deliberate and sustained smear campaign," it said. The Trust further clarified that the legal action is not retaliatory: 'But are in response to a sustained effort to discredit a respected charitable institution and its founding family without any supporting documentation or conclusive evidence from HDFC Bank to validate its claims." FIR and Financial Fraud Allegations Denying all allegations linking it to a company under scrutiny, the Trust said, 'The Trust and Prashant Mehta are not connected to the affairs of Splendour Gems in any manner whatsoever as fraudulently espoused by the CEO of HDFC." In response, earlier this week, HDFC Bank MD and CEO Sashidhar Jagdishan approached the Bombay High Court, seeking quashing of the FIR registered against him based on the financial fraud allegations made by the Lilavati Trust, which oversees the Mumbai-based Lilavati Hospital. The plea was mentioned before the court on Wednesday and will be heard in due course of time. The FIR stems from a magistrate court's order, directing the police to investigate the charges of alleged financial fraud. The Lilavati Kirtilal Mehta Medical Trust (LKMM Trust) has alleged in the complaint that of the Rs 14.42 crore misappropriated by its trustees, Rs 2.05 crore were received by Jagdishan. It also claimed that the offer of Rs 1.5 crore disguised as Corporate Social Responsibility (CSR) funds to hospital staff shows the intent to destroy evidence and obstruct justice. Despite judicial findings and multiple complaints, HDFC Bank failed to act, violating Section 166 of the Companies Act and SEBI governance mandates, the Trust alleged. The bank, however, has denied the allegations, calling it 'outrageous and preposterous".